WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2018015498) COMBINATIONS OF INECALCITOL WITH AN ANTI-CD38 AGENT AND THEIR USES FOR TREATING CANCER
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.:    WO/2018/015498    International Application No.:    PCT/EP2017/068379
Publication Date: 25.01.2018 International Filing Date: 20.07.2017
IPC:
A61K 31/593 (2006.01), A61K 39/395 (2006.01), A61P 35/02 (2006.01), C07K 16/28 (2006.01), C07K 16/30 (2006.01), C07K 16/40 (2006.01)
Applicants: HYBRIGENICS SA [FR/FR]; 3/5 Impasse Reille 75014 Paris (FR)
Inventors: BENJAMIN, Susan; (FR).
PLANQUETTE, Cécile; (FR).
DELANSORNE, Rémi; (FR)
Agent: COLOMBIE, Damien; (FR).
BLOT, Philippe; (FR).
DOMENEGO, Bertrand; (FR).
HABASQUE, Etienne; (FR).
HOLTZ, Béatrice; (FR).
NEYRET, Daniel; (FR)
Priority Data:
62/364,561 20.07.2016 US
Title (EN) COMBINATIONS OF INECALCITOL WITH AN ANTI-CD38 AGENT AND THEIR USES FOR TREATING CANCER
(FR) COMBINAISONS D'INÉCLACITOL AVEC UN AGENT ANTI-CD38 ET LEURS UTILISATIONS POUR LE TRAITEMENT DU CANCER
Abstract: front page image
(EN)The present disclosure concerns combinations of inecalcitol with an anti-CD38 agent such as daratumumab, MOR 202 or isatuximab for the treatment of cancer, such as hematological malignancies, by increasing or inducing the expression of CD-38 by inecalcitol.
(FR)La présente invention concerne des combinaisons d'inéclacitol avec un agent anti-CD38 tel que le daratumumab, MOR 202 ou l'isatuximab pour le traitement du cancer, tels que des malignités hématologiques, en augmentant ou en induisant l'expression de CD-38 par l'inéclacitol.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)